Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study. (30th July 2022)
- Record Type:
- Journal Article
- Title:
- Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study. (30th July 2022)
- Main Title:
- Correlation Between Postvaccination Anti-Spike Antibody Titers and Protection Against Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Population-Based Longitudinal Study
- Authors:
- Vivaldi, Giulia
Jolliffe, David A
Faustini, Sian
Shields, Adrian M
Holt, Hayley
Perdek, Natalia
Talaei, Mohammad
Tydeman, Florence
Chambers, Emma S
Cai, Weigang
Li, Wenhao
Gibbons, Joseph M
Pade, Corinna
McKnight, Áine
Shaheen, Seif O
Richter, Alex G
Martineau, Adrian R - Abstract:
- Abstract: In this population-based cohort of 7538 adults, combined immunoglobulin (Ig) G, IgA, and IgM (IgG/A/M) anti-spike titers measured after severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination were predictive of protection against breakthrough SARS-CoV-2 infection. Discrimination was significantly improved by adjustment for factors influencing risk of SARS-CoV-2 exposure, including household overcrowding, public transport use, and visits to indoor public places. Anti-spike IgG/A/M titers showed positive correlation with neutralizing antibody titers ( r s = 0.80 [95% confidence interval, .72–.86]; P < .001) and S peptide–stimulated interferon-γ concentrations ( r s = 0.31 [.13–.47]; P < .001). Abstract : Postvaccination anti-spike immunoglobulin (Ig) G, IgA, and IgM titers are modestly predictive of breakthrough severe acute respiratory syndrome coronavirus 2 infection but show poor correlation with interferon γ responses. Their limited predictive value for protection may therefore stem from their inability to reflect protective vaccine-induced cellular responses.
- Is Part Of:
- Journal of infectious diseases. Volume 226:Number 11(2022)
- Journal:
- Journal of infectious diseases
- Issue:
- Volume 226:Number 11(2022)
- Issue Display:
- Volume 226, Issue 11 (2022)
- Year:
- 2022
- Volume:
- 226
- Issue:
- 11
- Issue Sort Value:
- 2022-0226-0011-0000
- Page Start:
- 1903
- Page End:
- 1908
- Publication Date:
- 2022-07-30
- Subjects:
- SARS-CoV-2 -- breakthrough infection -- combined antibody response -- vaccination
Communicable diseases -- Periodicals
Diseases -- Causes and theories of causation -- Periodicals
Medicine -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.9 - Journal URLs:
- http://jid.oxfordjournals.org/content/by/year ↗
http://www.journals.uchicago.edu/JID/journal/ ↗
http://www.jstor.org/journals/00221899.html ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/infdis/jiac321 ↗
- Languages:
- English
- ISSNs:
- 0022-1899
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24769.xml